Moderna

News

ASCO: Moderna may file melanoma vaccine on phase 2b data

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme

News

Moderna gets FDA okay for RSV vaccine mResvia

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax C

News

FDA delays decision on Moderna’s RSV vaccine

Moderna’s first attempt to expand its commercial activities beyond COVID-19 vaccines, its respiratory syncytial virus (RSV) shot, has suffered a delay in the US.

News

Moderna banks on OpenAI to accelerate mRNA research

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI)

News

Blackstone bankrolls Moderna’s flu shot with $750m

Moderna’s efforts to develop a range of mRNA vaccines for influenza have been bolstered with funding of up to $750 million from investment firm Blackstone Life Sciences.

News

First patient treated with Moderna's PD-1/IDO1 cancer shot

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets th

ASCO: Moderna may file melanoma vaccine on phase 2b data

Moderna gets FDA okay for RSV vaccine mResvia

FDA delays decision on Moderna’s RSV vaccine

Moderna banks on OpenAI to accelerate mRNA research

Blackstone bankrolls Moderna’s flu shot with $750m

First patient treated with Moderna's PD-1/IDO1 cancer shot

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

Moderna

Editor's Picks